A Phase I Dose-Escalation Study of The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Polyethylene Glycol-Erythropoietin (PEG-EPO) in Healthy Subjects
Authors
Chaoying Hu (ORCID: https://orcid.org/0000-0002-0116-4387)
Wanling Sun (ORCID: https://orcid.org/0000-0001-9429-3024)
A Phase I Dose-Escalation Study of The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Polyethylene Glycol-Erythropoietin (PEG-EPO) in Healthy Subjects
Chaoying Hu, Wanling Sun, Xiangrong Zhang, Yuanyuan Wu et al.
Citations
2 citations
Journal
Clinical Therapeutics
Topics
Erythropoietin and Anemia Treatment
Field-Weighted Citation Impact (FWCI)
0.91
article
A Phase I Dose-Escalation Study of The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Polyethylene Glycol-Erythropoietin (PEG-EPO) in Healthy Subjects